|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-5-21
|
|
pubmed:abstractText |
Elaboration of our previously disclosed spiropiperidine template led to the development of a series of novel CCR5 antagonists. Results of SAR exploration and preliminary lead characterization are described.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1464-3405
|
|
pubmed:author |
pubmed-author:BerryPamelaP,
pubmed-author:DioszegiMariannaM,
pubmed-author:FilonovaLubovL,
pubmed-author:GabrielStephen DSD,
pubmed-author:HeilekGabrielleG,
pubmed-author:JekleAndreasA,
pubmed-author:JiChanghuaC,
pubmed-author:ManserNicoleN,
pubmed-author:PadillaFernandoF,
pubmed-author:RotsteinDavid MDM,
pubmed-author:SankuratriSuryaS,
pubmed-author:WellerPaulP,
pubmed-author:deRosierAndreA
|
|
pubmed:copyrightInfo |
Copyright 2010 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3219-22
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Synthesis, SAR and evaluation of [1,4']-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonists.
|
|
pubmed:affiliation |
Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, CA 94304, USA. david.rotstein@comcast.net
|
|
pubmed:publicationType |
Journal Article
|
